-
Mashup Score: 0Novel Drug Authorized for Critically Ill COVID-19 Patients - 1 year(s) ago
FDA grants EUA to anti-C5a antibody for patients on mechanical ventilation, ECMO
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The VIASURE PCR diagnostic is now available under Emergency Use Authorization in laboratories for persons with a suspected mpox infection.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The @US_FDA has granted Emergency Use Authorization (#EUA) to the monkeypox (mpox) PCR diagnostic VIASURE. https://t.co/GhYBrC2JCh
-
-
Mashup Score: 0
HHS’ Office of Inspector General found that by loosening emergency use authorization requirements to bring COVID-19 tests to market faster, the agency allowed inaccurate tests to be distributed.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet-
Watchdog faults #FDA for rushing #COVID19 #diagnostics tests to market by easing emergency use #EUA rules https://t.co/ko43CIvNhu
-
-
Mashup Score: 0FDA authorizes COVID vaccines in kids as young as 6 months - 2 year(s) ago
The data show that the “known and potential benefits” of the vaccines outweigh any potential risks, the agency said.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
#FDA grants #EUA to the Moderna and Pfizer COVID-19 vaccines for use in children 6 months of age and older. https://t.co/t9aiNHe321 https://t.co/wPzDjX8KjY
-
-
Mashup Score: 0FDA grants EUA for breathalyzer that detects COVID-19 - 2 year(s) ago
The FDA has authorized the first COVID-19 diagnostic test that detects chemicals associated with an infection in a person’s breath.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet-
#FDA grants #EUA for @inspect_ir #breathalyzer that detects #COVID19 | #diagnostics https://t.co/mOIOABZIdh https://t.co/zmW6IVDcQ1
-
-
Mashup Score: 7
Pfizer and BioNTech announced this week that they are seeking an emergency use authorization from the FDA for an additional booster dose of their COVID-19 vaccine for older adults. The companies have submitted an application for the EUA for adults aged 65 years or older who have already received a booster dose of any authorized COVID-19 vaccine.
Source: www.healio.comCategories: Infectious Disease, Latest HeadlinesTweet-
In this piece I give my perspective on #COVID19 vaccine 4th doses — I do not think they are indicated outside of high risk groups https://t.co/HHwl0PbTVR
-
Pfizer and BioNTech announced this week that they are seeking an #EUA from the FDA for an additional booster dose of their #COVID19 vaccine for older adults. @AmeshAA shares his thoughts: https://t.co/j3Mh3lpnQ7
-
-
Mashup Score: 1
The FDA granted an Emergency Use Authorization to Evusheld, AstraZeneca’s long-acting monoclonal antibodies for COVID-19 prevention in high-risk individuals.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#BREAKING The .@US_FDA granted Emergency Use Authorization (#EUA) to #Evusheld, .@AstraZeneca’s long-acting monoclonal antibodies for #COVID19 prevention in high-risk individuals. https://t.co/yntziVDhmF
-
-
Mashup Score: 0
As early as this week, Pfizer-BioNTech could request Emergency Use Authorization to administer COVID-19 booster doses to all adults 18 and older.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#BREAKING As early as this week, Pfizer-BioNTech is expected to request Emergency Use Authorization (#EUA) to administer #COVID19 booster doses to all adults. https://t.co/SqGAsQZnpY
-
-
Mashup Score: 10Merck asks US FDA to authorize promising anti-COVID pill | WTOP - 3 year(s) ago
Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic.
Source: WTOPCategories: Healthcare Professionals, Latest HeadlinesTweet-
Show us the #data! (I’ll also cross my fingers it’s effective so it does gain #EUA!) https://t.co/0K0jIkrvOf
-
-
Mashup Score: 24Molnupiravir Could Become the First Authorized COVID-19 Pill - 3 year(s) ago
Unpublished, interim phase 3 data show an approximate 50% reduction in hospitalizations and deaths versus placebo. Merck is expediting FDA application for the antiviral drug.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Molnupiravir showed significant efficacy in treating #COVID19 in phase 3 trials. Merck is now seeking FDA #EUA, to make it the first COVID-19 antiviral pill. https://t.co/a2pmGPl8fD
-
Novel Drug #Vilobelimab (#Gohibic) Authorized for Critically Ill #COVID-19 Patients — @US_FDA grants #EUA to #AntiC5aAntibody for patients on mechanical ventilation, #ECMO https://t.co/lmoyjd4hqJ @medpagetoday